During COVID-19 progression, the cytokine shift from the early type I IFN response to the late IL-18 inflammasome pathway response coordinated by CD14+CD16+ (intermediate) monocytes correlates with MAIT cell activation(61, 67). This evidence concerns the gene CD14 and COVID-19.